Neurogum Net Worth in 2025–2026: Valuation, Revenue, and the Shark Tank Story

Neurogum net worth is estimated at over $100 million as of 2025–2026. The company — founded in 2015 by Kent Yoshimura and Ryan Chen — walked away from Shark Tank without a deal in 2020 and has since grown into one of the more quietly impressive stories in the functional wellness space.

Neurogum — Key Facts at a Glance

What Is Neurogum?

The company started simply enough. Two student-athletes wanted a clean, portable energy source that didn't involve carrying a coffee or cracking open a can. So in 2015, Kent Yoshimura and Ryan Chen built one — a small piece of functional gum.

How the Product Works

Each piece contains natural caffeine sourced from green tea (around 40mg per piece — roughly half a cup of coffee), L-theanine, and B6 and B12 vitamins. The formula is absorbed through the oral mucosa rather than the digestive tract. In practice, that means users typically feel the effect faster than they would from a beverage or capsule — a delivery advantage that most competitors in the drink or pill format simply can't replicate.

The product is vegan, sugar-free, gluten-free, and aspartame-free. For a category historically loaded with artificial sweeteners, that positioning mattered — especially online, where ingredient-conscious buyers were actively looking for exactly this.

Current Product Line

What started as one SKU has expanded into five:

• Energy & Focus
• Extra Energy & Focus
• Calm & Clarity
• Sleep & Recharge
• Memory & Focus

Beyond retail consumers, Neuro has built a B2B channel selling bulk orders to companies for employee wellness programs. It's a quieter revenue stream, but one that adds meaningful recurring volume.

Where Neuro Sits in the Market

The functional gum and mint space is genuinely competitive. Neuro's closest comparables include Run Gum, OLLY, Alternascript, Ritual, and HUM Nutrition. What separates Neuro isn't just format — it's the combination of ingredient transparency, no artificial sweeteners, and a fast-absorption delivery method that most competitors in capsule or drink form can't easily replicate.

Why the Business Model Works

Before getting into the valuation numbers, it helps to understand the margin structure — because that's what makes the Neuro Gum story financially interesting.

Each piece costs approximately $0.67 to manufacture and retails around $3.99 per pack.

That's a healthy per-unit margin, and it compounds across three revenue channels:

1. Direct-to-consumer — subscription model via neurogum.com with strong repeat purchase rates
2. Retail — 20,000+ store locations across major chains
3. B2B corporate wellness — bulk orders from companies

Neuro also holds three active patents on its nutraceutical confectionery formulation — specifically the caffeine and L-theanine combination — originally filed in December 2014. That IP creates a meaningful barrier for anyone trying to copy the formula directly.

What's often overlooked is that the founders chose not to take Shark Tank money specifically to protect these margins. A royalty deal — like O'Leary's $0.50-per-unit offer on a $3.99 product — would have eaten significantly into profitability at scale. With 500M+ units sold lifetime, that single decision alone would have cost them tens of millions in royalty payments.

Neurogum on Shark Tank — What Actually Happened

The Pitch — Season 11, Episode 19 (2020)

Yoshimura and Chen walked onto Shark Tank asking for $750,000 in exchange for 5% equity — implying a $15 million company valuation. At the time, they were generating $3.5 million in annual revenue (up from $1.5 million the prior year) and were already in approximately 5,500 stores. By most standards, a reasonably strong position for a Shark Tank pitch.

The Offers and Why Both Were Rejected

Two Sharks made offers. Neither was accepted.

Robert Herjavec offered $1 million for 20% equity. The math on that deal implied a company valuation of just $5 million — well below what the founders were claiming. They passed.

Kevin O'Leary offered $750,000 for 5% equity, but attached a $0.50-per-unit royalty until he recovered $1 million. The royalty structure was the real problem. On a product priced at $3.99, a $0.50 royalty is a meaningful margin hit at any real scale. The founders declined.

They walked off without a deal, and Daniel Lubetzky later came on board as an investor and mentor post-show — which, in hindsight, validated the direction they were heading.

The Mark Cuban $30 Million Myth — Debunked

This claim comes up often, so it's worth addressing directly. A viral TikTok video circulated claiming Mark Cuban offered $30 million for Neuro Gum. It was fabricated — the video spliced together unrelated Shark Tank footage to create a false endorsement.

Cuban made no such offer at any point. The clip has misled a significant number of viewers who encountered it before finding any factual coverage of the brand.

Neurogum Net Worth and Valuation — What the Numbers Actually Show

A Quick Note on Private Company Valuations

Neuro Gum is a private company. That means no publicly filed valuation exists. Estimates like "$100M+" are derived from a combination of disclosed funding rounds, monthly revenue figures, and revenue multiples applied to comparable companies in the functional wellness space.

It's a reasonable estimate — but it's an estimate, not a certified number. Anyone presenting a single precise figure as confirmed fact is working from the same limited public information.

Valuation Timeline

Revenue and Sales Milestones

The revenue trajectory is what drives the valuation estimate more than anything else.

At the time of the Shark Tank pitch in 2020, annual revenue was $3.5 million. By 2023, that had grown to around $10–12 million annually.

The company now brings in over $10 million in revenue each month and is valued at over $100 million — figures attributed to a company spokesperson and documented across multiple sources, including Wikipedia's entry on Neuro (gum), which notes the brand ranked as the second fastest-growing company in Las Vegas on the Inc. 5000 for 2025.

Lifetime units sold stands at 500 million-plus. Some earlier reports cited 50 million — that figure appears to reflect an older, pre-2023 data point that was never updated to reflect current sales volume.

Funding History — From Crowdfunding to Series A

Source: PitchBook

What the Series A Was Actually For

Raising $8.25 million in February 2023 might seem counterintuitive for a brand already generating strong revenue. But retail shelf presence is expensive in ways that aren't obvious from the outside. Getting into 20,000+ stores requires upfront investment in logistics, inventory, slotting fees, and retail marketing — none of which is cheap.

The Series A funded that expansion, not the product itself. In practice, consumer brands in this space commonly find that physical retail growth requires capital well before the shelf revenue materializes.

Key Investors

• Aoki Labs (Steve Aoki) — late 2024; investor and brand ambassador
• Gold House Ventures Accelerator — early stage accelerator
• Mainstreet Investment — growth/expansion stage
• PM Equity Partner — corporate venture capital
• Pure Imagination Brands — angel group
• Fortune 100 company — strategic investor, name not publicly disclosed
• Daniel Lubetzky — post-Shark Tank investor and mentor

Founder Equity After Funding

The founders walked away from Shark Tank specifically to avoid dilution. Post-Series A, minority stakes have been distributed across eight investors. Available cap table data from PitchBook shows one early seed investor holding approximately 5.29% equity — suggesting overall dilution has been kept relatively controlled. The founders are understood to retain majority ownership, though exact current percentages have not been publicly confirmed.

What Drove Growth After Shark Tank

Retail Expansion

From roughly 5,500 stores at the time of their Shark Tank pitch, Neuro has grown to 20,000+ retail locations. The brand is now on shelves at Walmart, Target, CVS, Whole Foods, Walgreens, Vitamin Shoppe, and Meijer, and holds a category bestseller position on Amazon.

That kind of retail footprint doesn't happen by accident. It typically requires a combination of strong sell-through data, shelf-level marketing investment, and a product with a clearly defined value proposition — all of which Neuro appears to have in place.

TikTok Shop — A Meaningful Recent Driver

Neuro became one of the fastest-growing brands on TikTok Shop. The platform connects particularly well with younger, health-conscious consumers who are already skeptical of traditional energy drinks.

As reported by Forbes, TikTok Shop is acting as a breakout growth channel for consumer brands that can convert social discovery into real purchase volume — and Neuro's trajectory fits that pattern closely. Wellness brands in this space commonly report that TikTok-driven sales carry unusually high new-customer acquisition rates compared to traditional paid channels.

Organic Celebrity Mentions

Joe Rogan has mentioned the product more than ten times on his podcast — without any paid arrangement. That kind of unsolicited reach into millions of listeners who are actively interested in performance and wellness carries more credibility than a paid placement.

Steve Aoki's involvement as both investor and brand ambassador extends that reach into music and entertainment audiences, without the product needing to chase those demographics through advertising.

Conclusion

Neuro Gum's net worth has grown from a $15 million Shark Tank pitch valuation in 2020 to an estimated $100M+ by 2025–2026. Equity discipline, retail scale, strategic investors, and TikTok-driven growth all contributed. As a private company, the exact figure remains unverified — but the revenue trajectory makes the estimate credible.

Frequently Asked Questions

Q: What is Neuro Gum's net worth in 2025–2026?

Neuro Gum's estimated valuation is $100M+ as of 2025–2026, based on a monthly revenue run rate of $7M–$10M and figures attributed to a company spokesperson. It is a private company, so no official valuation has been publicly filed.

Q: Did Neuro Gum get a deal on Shark Tank?

No. Founders Kent Yoshimura and Ryan Chen rejected both offers on Shark Tank Season 11 — Robert Herjavec's $1M for 20% equity and Kevin O'Leary's $750K for 5% plus a $0.50 per-unit royalty. They left without a deal.

Q: Did Mark Cuban offer $30 million for Neuro Gum?

No. This claim came from a manipulated TikTok video splicing unrelated Shark Tank footage together. Mark Cuban made no offer to Neuro Gum at any point during or after the show.

Q: How much has Neuro Gum raised in total funding?

Neuro has raised $10.3 million across five rounds — from a $20.6K crowdfunding campaign in 2015 through to an $8.25M Series A in February 2023, with eight total investors on record.

Q: Do the founders still own Neuro Gum?

Kent Yoshimura and Ryan Chen are understood to retain majority ownership. Minority stakes have been distributed to investors across multiple funding rounds, but no transfer of majority control has been publicly disclosed.